I covered two infectious disease outbreaks in the last few months: fungal meningitis that spread from contaminated steroids at the New England Compounding Center, which represented one of the most damaging breakdowns of US drug safety in the past decade, and the outbreak of a novel strain of H7N9 avian influenza in China.
Meningitis outbreak reveals gaps in US drug regulation